amphetamine base en es it fr

amphetamine base Brand names, amphetamine base Analogs

amphetamine base Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

amphetamine base Chemical_Formula

C9H13N

amphetamine base RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

amphetamine base fda sheet

amphetamine base msds (material safety sheet)

amphetamine base Synthesis Reference

U. S. Pat. 1,879,003, (1932)

amphetamine base Molecular Weight

135.206 g/mol

amphetamine base Melting Point

Volatizes slowly at room temperature

amphetamine base H2O Solubility

Slightly

amphetamine base State

Solid

amphetamine base LogP

1.799

amphetamine base Dosage Forms

Capsules

amphetamine base Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

amphetamine base Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

amphetamine base Absorption

It forms easily absorbed molecules that are highly lipid soluble

amphetamine base side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

amphetamine base Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

amphetamine base Organisms Affected

Humans and other mammals